Global Digital Pathology Market – A Novel Approach in Cancer Diagnosis
Digital pathology plays a major role in advanced healthcare as it converts analog microscopic images into digital images. Digital pathology is a potential method for diagnosis of pathological condition of cancer and other diseases.
The global digital pathology market size was valued at US$ 335.0 million in 2017, and is expected to exhibit a CAGR of 12.5 % over the forecast period (2018 – 2026).
Figure 1. Global Digital Pathology Market Value (US$ Mn), by Region, 2017
Source: Coherent Market Insights Analysis (2018)
Increasing incidences of cancer is expected to propel growth of the digital pathology market
Digital pathology is a technology, which enables management and interpretation of pathological conditions from a simple slide to computer screen for better analysis and diagnosis. High prevalence of cancer is expected to drive the market growth. According to the World Health Organization (WHO), September 2018 Factsheet, in 2018, cancer was the second leading cause of death worldwide and around 9.6 million deaths were recorded due to the disease.
Moreover, increasing incidences of infectious diseases such as sexually transmitted diseases, malaria, and other diseases is also propelling growth of the digital pathology market over the forecast period. According to the World Health Organization (WHO), July 2018 Factsheet, around 71 million people have chronic hepatitis C infection worldwide and around 3,99,000 deaths occur annually from hepatitis C mostly due to cirrhosis and hepatocellular carcinoma.
However, factors such as high cost associated with diagnostic systems, stringent regulatory requirements, sampling errors, lack of standard guidelines, reimbursement status, and reproducibility and reliability concerns are expected to hinder the market growth.
Figure 2. Global Digital Pathology Market Share (%), by Application, 2018 and 2026
Source: Coherent Market Insights Analysis (2018)
Increasing government initiatives in North America is expected to bolster the market growth
North America holds dominant position in the global digital pathology market, owing to increasing government initiatives for diagnostics pathology and laboratory testing. For instance, in October 2015, The Centers for Global Health (CGH) partnered with the World Bank to support the East Africa Public Health Laboratory Networking Project. CGH also supports several programs for improving access to diagnostic pathology and laboratory medicines worldwide.
Moreover, increasing prevalence of cancer in this region is also expected to bolster the market growth over the forecast period. For instance, according to the International Agency for Research on Cancer (IARC), in 2018, around 2,378,785 new cases of cancer were recorded in North America.
Key players in the market are focused on receiving regulatory approvals for novel products to enhance their market share, which in turn is expected to boost the market growth. For instance, in April 2017, Philips IntelliSite Pathology Solution developed by Philips Digital Pathology Solutions received the U.S. Food and Drug Administration (FDA) approval for primary diagnosis in surgical pathology.
Major players operating in the global digital pathology market include, Ventana Medical Systems, Inc., Definiens AG, Omnyx, LLC, Hamamatsu Photonics K.K, Corista LLC, GE Healthcare, Inspirata Co, Philips Healthcare, 3D-Histech Ltd., Olympus Corporation, Sectra AB, Leica Biosystems, Apollo Enterprise Imaging, Visiopharm, Huron Digital Pathology, Indica Labs, and Perkin Elmer, Inc.
Digital pathology is an imaging system, which converts simple microscopic images into digital images for easy interpretation and analysis of histological slides in computer screens. It is widely used in screening of cancer, infectious diseases, and other disease conditions. It also aids in management and monitoring the progress of disease and related therapies. The digital pathology is improving accessibility and allows the teleconsultation services from pathologist which can improve the healthcare system.
Increasing prevalence of cancer, infectious diseases, and other conditions is a major factor driving the digital pathology market growth. According to the International Agency for Research on Cancer, 2018, around 18,078,957 new cases of cancer were registered worldwide in 2018. According to the same source, around 9,555,027 deaths occurred due to cancer worldwide in 2018.
Moreover, increasing clinical and preclinical trials are expected to boost the market growth. For instance, in March 2019, ClinicalTrials.gov listed 298,856 registered studies under clinical trials.
However, factors such as high cost associated with systems, lack of multiplanar focusing for cytology, lack of infrastructure and storage, adoption and validation requirements for new technology, stringent regulatory requirements, sampling errors, and lack of standard guidelines are expected to hinder the market growth.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 37 market data tables and 24 figures on "Digital Pathology Market - Global forecast to 2026”.
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.